Wutah dodolan YoY sajrone 12 wulan kepungkur: Harpoon Therapeutics (HARP)

Logo perusahaan publik Harpoon Therapeutics Corp (HARP)

A strategic alliance with industry leaders strengthens the position of Harpoon Therapeutics (HARP) in solid tumor therapy. The rolling year-over-year relative revenue change confirms the resilience of the model, where the 15.90 level serves as a critical benchmark. Margin stability is ensured by precision cold-chain logistics for components, while integration into a major pharmaceutical behemoth accelerates the development of trispecific antibodies, mitigating pricing risks during the research stage.

Wutah pendapatan YoY sajrone 12 wulan kepungkur Harpoon Therapeutics, Inc. (HARP): kanggo periode 11.02.2024 - 20.02.2024

Harpoon Therapeutics, Inc. (HARP) - rincian metrik lan laporan keuangan

Ringkesan analitik perusahaan:Harpoon Therapeutics
Sampel barang harpoontx.com

This indicator calculates trailing twelve-month (TTM) revenue dynamics, neutralizing short-term fluctuations to assess the fundamental stability of the business amid a market downturn. By analyzing the TTM sales volume change, an investor determines the margin of safety for Harpoon Therapeutics (HARP), which is supported by the international status of its oncology research and a strategic partnership with a US pharma behemoth.

Pesaing Harpoon Therapeutics (HARP)

Wutah dodolan YoY (TTM) NantKwest IBRX|IMCR - Wutah dodolan YoY sajrone rolas wulan kepungkur|JANX (januxrx.com) - Wutah dodolan YoY sajrone 12 wulan kepungkur|Arcus Corp (RCUS) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taun lumaku Zymeworks Corp (ZYME)|Wutah pendapatan YoY sajrone 12 wulan kepungkur TNGX|IOVA - Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur IMTX (Immatics Corp)|Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur XNCR|Wutah dodolan YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur REPL|lyell.com - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Innate Pharma S.A|Pyxis (PYXS) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Compugen Ltd - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|IOBT (iobiotech.com) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY (TTM) Sutro Biopharma Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur MiNK Therapeutics (INKT)|HOWL: Wutah dodolan taun lumaku|Immix Biopharma - Wutah pendapatan YoY sajrone 12 wulan kepungkur|ALX Oncology (ALXO) - Wutah pendapatan taun lumaku|CUE: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan taun lumaku PDSB|sonnetbio.com (SONN) - Wutah dodolan YoY sajrone rolas wulan kepungkur|MAIA Biotechnology Inc (MAIA) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone rolas wulan kepungkur liminatuspharma.com|Wutah dodolan YoY sajrone rolas wulan kepungkur LVTX|Wutah pendapatan YoY sajrone 12 wulan kepungkur NXTC (NextCure, Inc.)|LPTX: Wutah dodolan taun lumaku|Wutah dodolan YoY sajrone rolas wulan kepungkur intensitytherapeutics.com INTS|Sensei Bio (SNSE) - Wutah pendapatan taun lumaku|TOVX: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Gritstone bio - Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur|Kineta Bio (KA) - Wutah dodolan YoY sajrone rolas wulan kepungkur|NexImmune Inc (NEXI) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone rolas wulan kepungkur Turnstone Biologics Corp.|Wutah dodolan YoY sajrone 12 wulan kepungkur VCNX (Vaccinex, Inc.)